Different Formulations of Levothyroxine for Treating Hypothyroidism: A Real-Life Study.

Pierpaolo TrimboliLorenzo ScappaticcioAnnamaria De BellisMaria Ida MaiorinoLuisa KnappeKatherine EspositoGiuseppe BellastellaLuca M Giovanella

Published in: International journal of endocrinology (2020)

The performance of nonsolid LT4 formulations is not influenced by correct or incorrect use of therapy. On the contrary, LT4 tablet does not guarantee euthyroidism when it is ingested without waiting for at least 30 minutes before breakfast. These new data, obtained in a real-life scenario, suggest that LT4 SG/LS should be regarded as first-line therapy for treating adults with newly diagnosed hypothyroidism.

Keyphrases

newly diagnosed
replacement therapy
electronic health record
big data
stem cells
machine learning